81 Inclusion of PD-L1-expressing tumor cells in the combined positive score algorithm yields superior identification of positive specimens around diagnostic cut-offs across multiple indications

Bibliographic Details
Main Authors: Jonathan Juco, Kenneth Emancipator, Jay Milo, Christopher LaPlaca, Julia Hand, Stephanie Hund, Angeliki Apostolaki, Lindsay Guerrero, Bryce Portier, Siena Tabuena-Frolli, Karina Kulangara
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-7b9b4320493b422aa39f3364a327caac
record_format Article
spelling doaj-7b9b4320493b422aa39f3364a327caac2020-12-11T10:04:14ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.008181 Inclusion of PD-L1-expressing tumor cells in the combined positive score algorithm yields superior identification of positive specimens around diagnostic cut-offs across multiple indicationsJonathan Juco0Kenneth Emancipator1Jay Milo2Christopher LaPlaca3Julia Hand4Stephanie Hund5Angeliki Apostolaki6Lindsay Guerrero7Bryce Portier8Siena Tabuena-Frolli9Karina Kulangara102Merck, Kenilworth, NJ, USAMerck and Co., Inc., Kenilworth, NJ, USA1Agilent, Carpinteria, CA, USA1Agilent, Carpinteria, CA, USA1Agilent, Carpinteria, CA, USA1Agilent, Carpinteria, CA, USA1Agilent, Carpinteria, CA, USA1Agilent, Carpinteria, CA, USA1Agilent, Carpinteria, CA, USA1Agilent, Carpinteria, CA, USA1Agilent, Carpinteria, CA, USA
collection DOAJ
language English
format Article
sources DOAJ
author Jonathan Juco
Kenneth Emancipator
Jay Milo
Christopher LaPlaca
Julia Hand
Stephanie Hund
Angeliki Apostolaki
Lindsay Guerrero
Bryce Portier
Siena Tabuena-Frolli
Karina Kulangara
spellingShingle Jonathan Juco
Kenneth Emancipator
Jay Milo
Christopher LaPlaca
Julia Hand
Stephanie Hund
Angeliki Apostolaki
Lindsay Guerrero
Bryce Portier
Siena Tabuena-Frolli
Karina Kulangara
81 Inclusion of PD-L1-expressing tumor cells in the combined positive score algorithm yields superior identification of positive specimens around diagnostic cut-offs across multiple indications
Journal for ImmunoTherapy of Cancer
author_facet Jonathan Juco
Kenneth Emancipator
Jay Milo
Christopher LaPlaca
Julia Hand
Stephanie Hund
Angeliki Apostolaki
Lindsay Guerrero
Bryce Portier
Siena Tabuena-Frolli
Karina Kulangara
author_sort Jonathan Juco
title 81 Inclusion of PD-L1-expressing tumor cells in the combined positive score algorithm yields superior identification of positive specimens around diagnostic cut-offs across multiple indications
title_short 81 Inclusion of PD-L1-expressing tumor cells in the combined positive score algorithm yields superior identification of positive specimens around diagnostic cut-offs across multiple indications
title_full 81 Inclusion of PD-L1-expressing tumor cells in the combined positive score algorithm yields superior identification of positive specimens around diagnostic cut-offs across multiple indications
title_fullStr 81 Inclusion of PD-L1-expressing tumor cells in the combined positive score algorithm yields superior identification of positive specimens around diagnostic cut-offs across multiple indications
title_full_unstemmed 81 Inclusion of PD-L1-expressing tumor cells in the combined positive score algorithm yields superior identification of positive specimens around diagnostic cut-offs across multiple indications
title_sort 81 inclusion of pd-l1-expressing tumor cells in the combined positive score algorithm yields superior identification of positive specimens around diagnostic cut-offs across multiple indications
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT jonathanjuco 81inclusionofpdl1expressingtumorcellsinthecombinedpositivescorealgorithmyieldssuperioridentificationofpositivespecimensarounddiagnosticcutoffsacrossmultipleindications
AT kennethemancipator 81inclusionofpdl1expressingtumorcellsinthecombinedpositivescorealgorithmyieldssuperioridentificationofpositivespecimensarounddiagnosticcutoffsacrossmultipleindications
AT jaymilo 81inclusionofpdl1expressingtumorcellsinthecombinedpositivescorealgorithmyieldssuperioridentificationofpositivespecimensarounddiagnosticcutoffsacrossmultipleindications
AT christopherlaplaca 81inclusionofpdl1expressingtumorcellsinthecombinedpositivescorealgorithmyieldssuperioridentificationofpositivespecimensarounddiagnosticcutoffsacrossmultipleindications
AT juliahand 81inclusionofpdl1expressingtumorcellsinthecombinedpositivescorealgorithmyieldssuperioridentificationofpositivespecimensarounddiagnosticcutoffsacrossmultipleindications
AT stephaniehund 81inclusionofpdl1expressingtumorcellsinthecombinedpositivescorealgorithmyieldssuperioridentificationofpositivespecimensarounddiagnosticcutoffsacrossmultipleindications
AT angelikiapostolaki 81inclusionofpdl1expressingtumorcellsinthecombinedpositivescorealgorithmyieldssuperioridentificationofpositivespecimensarounddiagnosticcutoffsacrossmultipleindications
AT lindsayguerrero 81inclusionofpdl1expressingtumorcellsinthecombinedpositivescorealgorithmyieldssuperioridentificationofpositivespecimensarounddiagnosticcutoffsacrossmultipleindications
AT bryceportier 81inclusionofpdl1expressingtumorcellsinthecombinedpositivescorealgorithmyieldssuperioridentificationofpositivespecimensarounddiagnosticcutoffsacrossmultipleindications
AT sienatabuenafrolli 81inclusionofpdl1expressingtumorcellsinthecombinedpositivescorealgorithmyieldssuperioridentificationofpositivespecimensarounddiagnosticcutoffsacrossmultipleindications
AT karinakulangara 81inclusionofpdl1expressingtumorcellsinthecombinedpositivescorealgorithmyieldssuperioridentificationofpositivespecimensarounddiagnosticcutoffsacrossmultipleindications
_version_ 1724386461730471936